Company logo

HOLX - Hologic, Inc.

NASDAQ -> Healthcare -> Medical Instruments & Supplies
Marlborough, United States
Type: Equity

HOLX price evolution
HOLX
(in millions $) 30 Oct 2024 30 Jun 2024 30 Apr 2024 31 Dec 2023
Current assets
Cash $2439.1 $2180 $1932.1
Short term investments
Net receivables $600.4 $628.5 $647.1 $670.9
Inventory $679.8 $665.5 $649.2 $633.6
Total current assets $3823.3 $3997 $3788.7 $3494.2
Long term investments
Property, plant & equipment $537.8 $528.8 $524.8 $527
Goodwill & intangible assets $3978.7 $4044.3 $4138.6
Total noncurrent assets $4893.1 $4925.7 $4975.3
Total investments
Total assets $9156 $8890.1 $8714.4 $8469.5
Current liabilities
Accounts payable $786.8 $202 $911.7 $183.8
Deferred revenue $233.8 $222.8 $204.8
Short long term debt $40.7 $40.6 $40.6
Total current liabilities $1037.2 $1002.4 $954.6 $899
Long term debt $2497.1 $2518.5 $2527.9 $2537.4
Total noncurrent liabilities $2936.8 $2915.4 $2916.7
Total debt $2559.2 $2568.5 $2578
Total liabilities $4026 $3939.2 $3870 $3815.7
Shareholders' equity
Retained earnings $2845.8 $2667.2 $2472.7 $2302.8
Other shareholder equity $5130 -$139.5 -$137 -$118.8
Total shareholder equity $4950.9 $4844.4 $4653.8
(in millions $) 28 Oct 2024 30 Oct 2023 24 Oct 2022 31 Dec 2021
Current assets
Cash $2722.5 $2339.5 $1170.3
Short term investments
Net receivables $600.4 $625.6 $617.6 $942.7
Inventory $679.8 $617.6 $623.7 $501.2
Total current assets $3823.3 $4184.5 $3862 $3168.7
Long term investments
Property, plant & equipment $537.8 $517 $481.6 $564.7
Goodwill & intangible assets $4169.9 $4517.1 $4940.8
Total noncurrent assets $4954.8 $5209.2 $5751.2
Total investments
Total assets $9156 $9139.3 $9071.2 $8919.9
Current liabilities
Accounts payable $786.8 $712.9 $197.7 $215.9
Deferred revenue $213 $195.9 $218.3
Short long term debt $290.1 $18.2 $316.7
Total current liabilities $1037.2 $1207.3 $937.7 $1326.8
Long term debt $2497.1 $2531.2 $2808.4 $2735
Total noncurrent liabilities $2915.1 $3257.3 $3374.5
Total debt $2836.6 $2844.6 $3051.7
Total liabilities $4026 $4122.4 $4195 $4701.3
Shareholders' equity
Retained earnings $2845.8 $2056.3 $1600.3 $298.3
Other shareholder equity $5130 $5016.9 $4876.2 -$59.1
Total shareholder equity $5016.9 $4876.2 $4218.6
(in millions $) 31 Jan 2025 30 Oct 2024 30 Jun 2024 31 Mar 2024
Revenue
Total revenue $1011.4 $1017.8
Cost of revenue $451.1 $475.5
Gross Profit $560.3 $542.3
Operating activities
Research & development $64.1 $74.6
Selling, general & administrative $240.3 $244.6
Total operating expenses $316.3 $331.9
Operating income $244 $210.4
Income from continuing operations
EBIT $272.6 $243.8
Income tax expense $46.2 $41.6
Interest expense $31.9 $32.3
Net income
Net income $194.5 $169.9
Income (for common shares) $194.5 $169.9
(in millions $) 28 Oct 2024 30 Oct 2023 24 Oct 2022 31 Jan 2022
Revenue
Total revenue $4030.3 $4030.4 $4862.8
Cost of revenue
Gross Profit $2267 $2251 $3014.8
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $1296.8 $1310 $1366.6
Operating income
Income from continuing operations
EBIT
Income tax expense $75.6 $220.1 $286.2
Interest expense -$15.1 $24.3 -$42.7
Net income
Net income $789.5 $456 $1302
Income (for common shares)
(in millions $) 28 Oct 2024 30 Jun 2024 31 Mar 2024 31 Dec 2023
Net income $194.5 $169.9 $246.5
Operating activities
Depreciation $72.3 $73.7 $88.4
Business acquisitions & disposals -$31.3
Stock-based compensation $14.6 $25.8 $28.7
Total cash flows from operations $405.8 $292.4 $220
Investing activities
Capital expenditures -$43.9 -$28 -$38
Investments -$3 -$5 -$34.5
Total cash flows from investing -$781 -$42.6 -$38.5 -$104.2
Financing activities
Dividends paid
Sale and purchase of stock -$93.2 $8.9 -$667.3
Net borrowings -$10.3 -$10.4 -$260.3
Total cash flows from financing -$1108.6 -$103.8 -$4.2 -$943.8
Effect of exchange rate $8.9 -$0.3 -$1.8 $4.4
Change in cash and equivalents -$595.5 $259.1 $247.9 -$823.6
(in millions $) 28 Oct 2024 30 Oct 2023 24 Oct 2022 31 Dec 2021
Net income $1871.5
Operating activities
Depreciation $406.9
Business acquisitions & disposals -$1164.7
Stock-based compensation $65
Total cash flows from operations $2330.4
Investing activities
Capital expenditures -$162.7
Investments
Total cash flows from investing -$781 -$152.1 -$206.3 -$1329.6
Financing activities
Dividends paid
Sale and purchase of stock -$358.5
Net borrowings -$113.4
Total cash flows from financing -$1108.6 -$483.2 -$756 -$529.8
Effect of exchange rate $8.9 $0.3 $5.8 -$1.7
Change in cash and equivalents -$595.5 $416.2 $1169.2 $469.3
Fundamentals
Market cap $16.76B
Enterprise value N/A
Shares outstanding 232.27M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q N/A
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio N/A
Book/Share N/A
Cash/Share N/A
EPS N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 3.69
Quick ratio 3.03